News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
502,061 Results
Type
Article (52524)
Company Profile (132)
Press Release (449405)
Section
Business (136748)
Career Advice (1030)
Deals (20889)
Drug Delivery (71)
Drug Development (62354)
Employer Resources (93)
FDA (13605)
Job Trends (11054)
News (238466)
Policy (23164)
Tag
Academia (2850)
Alliances (34951)
Alzheimer's disease (1019)
Approvals (13583)
Artificial intelligence (116)
Bankruptcy (171)
Best Places to Work (8736)
Biotechnology (92)
Breast cancer (157)
Cancer (1124)
Cardiovascular disease (91)
Career advice (873)
Cell therapy (206)
Clinical research (50370)
Collaboration (341)
Compensation (85)
COVID-19 (2218)
C-suite (106)
Data (1194)
Diabetes (130)
Diagnostics (4531)
Earnings (43076)
Employer resources (82)
Events (71105)
Executive appointments (362)
FDA (14195)
Funding (300)
Gene therapy (138)
GLP-1 (431)
Government (3717)
Healthcare (15481)
Infectious disease (2291)
Inflammatory bowel disease (84)
Interviews (131)
IPO (9013)
Job creations (2642)
Job search strategy (806)
Layoffs (229)
Legal (4592)
Lung cancer (166)
Lymphoma (82)
Manufacturing (123)
Medical device (13362)
Medtech (13366)
Mergers & acquisitions (12020)
Metabolic disorders (345)
Neuroscience (1264)
NextGen Class of 2024 (5430)
Non-profit (3983)
Northern California (1134)
Obesity (193)
Opinion (93)
Patents (82)
People (47723)
Phase I (15190)
Phase II (22179)
Phase III (16858)
Pipeline (371)
Postmarket research (2171)
Preclinical (5982)
Radiopharmaceuticals (204)
Rare diseases (196)
Real estate (4721)
Regulatory (16040)
Research institute (2280)
Resumes & cover letters (135)
Southern California (1004)
Startups (2875)
United States (11120)
Vaccines (467)
Weight loss (134)
Date
Today (27)
Last 7 days (416)
Last 30 days (1669)
Last 365 days (25455)
2024 (25349)
2023 (29435)
2022 (38857)
2021 (41535)
2020 (40693)
2019 (36954)
2018 (28111)
2017 (24324)
2016 (24225)
2015 (28362)
2014 (21885)
2013 (19473)
2012 (20790)
2011 (20679)
2010 (18809)
Location
Africa (545)
Arizona (120)
Asia (30814)
Australia (5400)
California (2544)
Canada (1039)
China (248)
Colorado (132)
Connecticut (140)
Europe (65666)
Florida (402)
Georgia (112)
Illinois (333)
Indiana (188)
Maryland (521)
Massachusetts (2239)
Michigan (110)
Minnesota (223)
New Jersey (828)
New York (781)
North Carolina (559)
Northern California (1134)
Ohio (123)
Pennsylvania (689)
South America (775)
Southern California (1004)
Texas (405)
Utah (80)
Washington State (236)
502,061 Results for "boston university medical center".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Gene therapy
Lilly Opens $700M R&D Center in Boston for Genetic Medicines
Eli Lilly’s new research and development facility in Boston’s Seaport district will focus on DNA- and RNA-based therapies, as well as other priority areas such as diabetes and obesity.
August 14, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Takeda and Boston Medical Center Announce Innovative Collaboration to Help Tackle Decarbonization Across Health Care Ecosystem
October 25, 2024
·
8 min read
Biotech Bay
Complete Genomics expands to East Coast with new Customer Experience Center in Greater Boston’s Biotech Hub
Complete Genomics, a pioneering genomic sequencing company, announced the May 22 opening of its Customer Experience Center demonstration lab near Boston’s biotech hub.
May 21, 2024
·
2 min read
Press Releases
Femasys Announces Partnership with Boston IVF, Prominent Network of Fertility Centers, to Offer FemaSeed
October 30, 2024
·
7 min read
Business
QT Imaging Holdings’ Technology Advances Medical Imaging Research at the University of Oklahoma’s Health Stephenson Cancer Center
QT Imaging Holdings, Inc. is honored to partner with University of Oklahoma and OU Health Stephenson Cancer Center to advance and scale innovative research in medical imaging and to improve precision in cancer detection and treatment.
June 24, 2024
·
5 min read
BioMidwest
University of Cincinnati Cancer Center Launches Nation’s Most Comprehensive Blood Cancer Healing Center
The University of Cincinnati Cancer Center inaugurated its state-of-the-art Blood Cancer Healing Center, revolutionizing blood cancer care in the United States.
June 24, 2024
·
4 min read
BioCapital
Enrollment in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis to Begin at Tufts Medical Center; First Study of Its Kind
60 Degrees Pharmaceuticals, Inc. announced it has entered into an agreement with Tufts Medical Center in Boston to conduct the world’s first clinical trial evaluating the efficacy and safety of tafenoquine in treating human babesiosis patients.
May 30, 2024
·
11 min read
Genetown
Boston Medical Center to Offer First FDA-Approved Gene Therapy Treatment Program for Sickle Cell Disease
Boston Medical Center (BMC), a national leader in the treatment of sickle cell disease for more than 50 years, announced today that it will offer the first-ever gene therapy treatment program for sickle cell disease that uses a type of novel genome editing technology.
December 8, 2023
·
4 min read
Press Releases
Naropa University Announces Separation of Center For Psychedelic Studies
December 16, 2024
·
4 min read
Drug Development
University of Nebraska Medical Center Launches Patient Enrollment for RenovoRx’s Pivotal Phase III TIGeR-PaC Clinical Trial
RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, announced today that the University of Nebraska Medical Center (UNMC) is now enrolling patients with Locally Advanced Pancreatic Cancer (LAPC) in the Company’s ongoing pivotal Phase III TIGeR-PaC clinical trial.
June 26, 2024
·
9 min read
1 of 50,207
Next